Bioray Biotech Co., Ltd
TWO: 7561.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ting-Yuan Hsu
- Employees
- 79
- Headquarters
- Pingtung, Taiwan
- IPO year
- 2020
- Market cap
- NT$606.5M
- Website
- https://www.bio-ray.com.tw
Loading 7561…
Loading profile data…Frequently asked questions about 7561
What does Bioray Biotech Co., Ltd (7561.TWO) do?
Bioray Biotech Co., Ltd engages in the research and development, manufacture, and sale of biological and health supplement products. Its biological products include functional probiotics, medicinal fungi, and immune cell preparations. The company is also involved in the cell testing and storage business. Bioray Biotech Co., Ltd was founded in 19...
Where does 7561.TWO trade?
Bioray Biotech Co., Ltd (7561.TWO) trades on the Taipei Exchange.
What sector is 7561.TWO in?
Bioray Biotech Co., Ltd (7561.TWO) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Bioray Biotech Co., Ltd?
Ting-Yuan Hsu is the chief executive officer of Bioray Biotech Co., Ltd (7561.TWO).
Where is Bioray Biotech Co., Ltd headquartered?
Bioray Biotech Co., Ltd is headquartered in Taiwan.
Does 7561.TWO pay a dividend?
Bioray Biotech Co., Ltd (7561.TWO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 7561.TWO go public?
Bioray Biotech Co., Ltd (7561.TWO) completed its initial public offering in 2020.